{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-030878","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2024-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.917855+00:00","generated_at":"2026-05-30T18:32:44.197070+00:00","sec_items":["1.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Vaxart terminates at-the-market equity offering agreement with Cantor, B. Riley","bullets":["Termination effective October 18, 2024; no termination penalties incurred.","From Sept 2021 to Oct 2024, Vaxart sold 17.5M shares for ~$28.6M gross proceeds under the ATM.","After termination, Vaxart may not offer or sell additional shares under the Sales Agreement.","No reason for termination disclosed; may signal a shift in capital-raising strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-030878","json":"https://secwatch.observer/filing/0001437749-24-030878.json","markdown":"https://secwatch.observer/filing/0001437749-24-030878.md","text":"https://secwatch.observer/filing/0001437749-24-030878.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774924030878/0001437749-24-030878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774924030878/vxrt20241007_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T18:32:44.197070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}